欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/0438/003
药品名称
bica Nova 4,25% Glucose
活性成分
calcium chloride 0.36 g
glucose 10.99 g
剂型
Solution for peritoneal dialysis
上市许可持有人
Fresenius Medical Care Deutschland GmbH Else-Kroener-Str. 1 D-61352 Bad Homburg v.d.H. Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Italy (IT)
许可日期
2005/07/26
最近更新日期
2021/11/10
药物ATC编码
B05DB Hypertonic solutions
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Bibliographic [Article 10.1(a)(ii)]
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
common_impack_bicanova15sls_201508
Date of last change:2024/09/06
Final Product Information
|
common_impack_bicanova15sts_201508
Date of last change:2024/09/06
Final Product Information
|
common_impack_bicanova23sls_201508
Date of last change:2024/09/06
Final Product Information
|
common_impack_bicanova23sts_201508
Date of last change:2024/09/06
Final Product Information
|
common_impack_bicanova425sls_201508
Date of last change:2024/09/06
Final Product Information
|
common_impack_bicanova425sts_201508_rev
Date of last change:2024/09/06
Final Product Information
|
common_outer_bicanova15sls_201508
Date of last change:2024/09/06
Final Product Information
|
common_outer_bicanova15sts_201508
Date of last change:2024/09/06
Final Product Information
|
common_outer_bicanova23sls_201508
Date of last change:2024/09/06
Final Product Information
|
common_outer_bicanova23sts_201508_rev
Date of last change:2024/09/06
Final Product Information
|
common_outer_bicanova425sls_201508
Date of last change:2024/09/06
Final Product Information
|
common_outer_bicanova425sts_201508_rev
Date of last change:2024/09/06
Final Product Information
|
common_pl_bicanova15_201508
Date of last change:2024/09/06
Final PL
|
common_pl_bicanova15_201905
Date of last change:2024/09/06
Final PL
|
common_pl_bicanova15_201905_track
Date of last change:2024/09/06
Final Product Information
|
common_pl_bicanova23_201508
Date of last change:2024/09/06
Final PL
|
common_pl_bicanova23_201905
Date of last change:2024/09/06
Final PL
|
common_pl_bicanova23_201905_track
Date of last change:2024/09/06
Final Product Information
|
common_pl_bicanova425_201508
Date of last change:2024/09/06
Final PL
|
common_pl_bicanova425_201905
Date of last change:2024/09/06
Final PL
|
common_pl_bicanova425_201905_track
Date of last change:2024/09/06
Final Product Information
|
common_spc_bicanova15_201508
Date of last change:2024/09/06
Final SPC
|
common_spc_bicanova15_201905
Date of last change:2024/09/06
Final SPC
|
common_spc_bicanova15_201905_track
Date of last change:2024/09/06
Final Product Information
|
common_spc_bicanova23_201508
Date of last change:2024/09/06
Final SPC
|
common_spc_bicanova23_201905
Date of last change:2024/09/06
Final SPC
|
common_spc_bicanova23_201905_track
Date of last change:2024/09/06
Final Product Information
|
common_spc_bicanova425_201508
Date of last change:2024/09/06
Final SPC
|
common_spc_bicanova425_201905
Date of last change:2024/09/06
Final SPC
|
common_spc_bicanova425_201905_track
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase